{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:03:44Z","timestamp":1791349424110,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.vaccine.2010.04.057","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T06:10:41Z","timestamp":1274076641000},"page":"4837-4841","source":"Crossref","is-referenced-by-count":56,"title":["A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome"],"prefix":"10.1016","volume":"28","author":[{"given":"Alessandra","family":"Handisurya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Schellenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"Reininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieder","family":"Koszik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Vyhnanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heitger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kirnbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"F\u00f6rster-Waldl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.04.057_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-9343(90)90187-I","article-title":"A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia","volume":"89","author":"Wetzler","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2010.04.057_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOH.0b013e32831ac557","article-title":"WHIM syndrome: congenital immune deficiency disease","volume":"16","author":"Kawai","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2010.04.057_bib4","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2004-06-2289","article-title":"WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12","volume":"105","author":"Balabanian","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2010.04.057_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood-2003-10-3532","article-title":"Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome","volume":"104","author":"Gulino","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2010.04.057_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.exphem.2005.01.001","article-title":"Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome","volume":"33","author":"Kawai","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib7","first-page":"1074","article-title":"Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling","volume":"118","author":"Balabanian","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2010.04.057_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9","article-title":"WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies","volume":"91","author":"Gorlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.vaccine.2010.04.057_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11882-005-0005-0","article-title":"WHIM syndrome: a defect in CXCR4 signaling","volume":"5","author":"Diaz","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.vaccine.2010.04.057_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM196404022701402","article-title":"\u201cMyelokathexis\u201d\u2014a new form of chronic granulocytopenia. Report of a case","volume":"270","author":"Zuelzer","year":"1964","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.04.057_bib11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/blood.V95.1.320","article-title":"a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors","volume":"95","author":"Aprikyan","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2010.04.057_bib12","series-title":"Dermatology, vol. 1","first-page":"1183","article-title":"Human Papillomavirus","author":"Kirnbauer","year":"2008"},{"key":"10.1016\/j.vaccine.2010.04.057_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1610-0387.2009.06988.x","article-title":"Diseases caused by human papillomaviruses (HPV)","volume":"7","author":"Handisurya","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.vaccine.2010.04.057_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.04.057_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jaci.2005.08.040","article-title":"Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome","volume":"116","author":"Tarzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2010.04.057_bib16","doi-asserted-by":"crossref","first-page":"K53","DOI":"10.1016\/j.vaccine.2008.06.002","article-title":"An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results","volume":"26","author":"Schiller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.04.057_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI28607","article-title":"Prophylactic human papillomavirus vaccines","volume":"116","author":"Lowy","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2010.04.057_bib18","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.04.057_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJMct0806938","article-title":"HPV vaccination for the prevention of cervical intraepithelial neoplasia","volume":"361","author":"Kahn","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.04.057_bib20","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2010.04.057_bib21","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1099\/0022-1317-75-9-2445","article-title":"Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles","volume":"75","author":"Rose","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib22","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/JVI.67.12.6929-6936.1993","article-title":"Efficient self-assembly of human papillomavirus type 16 L1 and L1\u2013L2 into virus-like particles","volume":"67","author":"Kirnbauer","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1099\/vir.0.006189-0","article-title":"Serological relationship between cutaneous human papillomavirus types 5, 8 and 92","volume":"90","author":"Handisurya","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib24","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.4049\/jimmunol.177.4.2662","article-title":"Papillomavirus-like particles are an effective platform for amyloid-beta immunization in rabbits and transgenic mice","volume":"177","author":"Zamora","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jnci\/86.7.494","article-title":"A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16","volume":"86","author":"Kirnbauer","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2010.04.057_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/JVI.78.2.751-757.2004","article-title":"Efficient intracellular assembly of papillomaviral vectors","volume":"78","author":"Buck","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib27","first-page":"445","article-title":"Generation of HPV pseudovirions using transfection and their use in neutralization assays","volume":"119","author":"Buck","year":"2005","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.vaccine.2010.04.057_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2003.12.027","article-title":"Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18","volume":"321","author":"Pastrana","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.04.057_bib29","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1128\/JVI.01088-09","article-title":"Chimeric L1\u2013L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines","volume":"83","author":"Schellenbacher","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib30","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/JVI.69.6.3959-3963.1995","article-title":"Immunization with virus like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection","volume":"69","author":"Breitburd","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib31","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2010.04.057_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM197708042970503","article-title":"Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child","volume":"297","author":"Davis","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.04.057_bib33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1651-2227.1980.tb07131.x","article-title":"Vaccine-associated poliomyelitis in an infant with agammaglobulinemia","volume":"69","author":"Sankano","year":"1980","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.vaccine.2010.04.057_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/599988","article-title":"Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials","volume":"200","author":"Schiller","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.04.057_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.04.057_bib36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"10.1016\/j.vaccine.2010.04.057_bib37","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1016\/j.vaccine.2008.09.073","article-title":"HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine","volume":"26","author":"Joura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.04.057_bib38","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1128\/JVI.76.15.7832-7842.2002","article-title":"Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine","volume":"76","author":"Emeny","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.04.057_bib39","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/320190","article-title":"A phase 1 study of a recombinant virus like particle vaccine against human papillomavirus type 11 in healthy adult volunteers","volume":"183","author":"Evans","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.04.057_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/376505","article-title":"Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles","volume":"188","author":"Pinto","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.04.057_bib41","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like particle (VLP) vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10005815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10005815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T18:29:05Z","timestamp":1591295345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10005815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":41,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0264410X10005815"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}